Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

38.21
+8.5428.78%
Volume:350.05K
Turnover:12.93M
Market Cap:58.02M
PE:- -
High:39.05
Open:31.39
Low:31.39
Close:29.67
52wk High:152.22
52wk Low:11.52
Shares:1.52M
Float Shares:1.52M
Volume Ratio:2.73
T/O Rate:23.06%
Dividend:3.85
Dividend Rate:10.07%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Median Technologies Partners with Canon’s Olea Medical to Commercialize Eyonis LCS Lung Cancer Screening Software

Reuters
·
Jul 30

Sløk Flags Systemic Cross-Asset Risks; AI Turmoil Is Just The Starting Point

Analyst Calls
·
Jul 30

More Cracks Appear Inside The AI Bond Market!

AI Industry Frontlines
·
Jul 28

Anthropic Considers Mandatory Stock Trading Plan For All Employees Ahead Of IPO, Breaking Industry Norms

Hong Kong & US IPO Tracker
·
Jul 27

AI Sector Under Massive Valuation Reset: Market Abandons Blind Capex Hype, Focuses On Cash Flow & ROI

Bellwether Stocks Movement
·
Jul 27

SAP CFO: Generic Chatbots Bring Little Profit; Enterprise Process AI Is True Growth Driver

Analyst Calls
·
Jul 24

Tempus AI announces national launch of OneOme pharmacogenomics testing

TIPRANKS
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Immunome (IMNM) and Incyte (INCY)

TIPRANKS
·
Jul 22

Analysts Are Neutral on These Healthcare Stocks: Cencora (COR), Avita Medical (RCEL)

TIPRANKS
·
Jul 22

Tempus AI (TEM) Stock May Trade Below Fair Value Despite Mixed Checks

Simply Wall St.
·
Jul 22

Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained

TIPRANKS
·
Jul 22

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Benzinga_recent_news
·
Jul 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tempus AI, Inc. Class A (TEM) and 4D Molecular Therapeutics (FDMT)

TIPRANKS
·
Jul 21

AI Bull Run Hits A Crossroads! Wall Street Erupts In Rare Bull-Bear Showdown

AI Industry Frontlines
·
Jul 21

Personalis Acquisition Price Warranted by Growth Prospects, Needham Says

MT Newswires Live
·
Jul 21

Morgan Stanley sees strategic logic in Personalis deal despite financial hurdles

TIPRANKS
·
Jul 21

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

TIPRANKS
·
Jul 21

Top Midday Decliners

MT Newswires Live
·
Jul 21

Tempus AI Price Target Maintained with a $75.00/share by Needham

Dow Jones
·
Jul 21

Midday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis

TIPRANKS
·
Jul 21